Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Frequently Asked Questions

Is the process still the same as “back in my day”? That is - CDC Staff review the NOFO document and then call participants have an opportunity to ask clarifying questions.

Yes, this is the same call format.

Update: Call was held April 16, 2018 at 3:00pm EST. Recording of the call can be accessed via:  https://ondieh.adobeconnect.com/pkmnvf5oek1h/

P 27 references Office of Budget Management review and approval of information collection. Does this mean that all needs assessments and surveys, funded through this NOFO and that target 10 or more individuals or entities, require OMB review and approval, and, if so, what amount of time should be built into the workplan timeframe for approval?

The Paperwork Reduction Act includes the following information about conducting or sponsoring data collections (i.e., needs assessments and other tools):

  1. d) Conduct or Sponsor. A Federal agency is considered to “conduct or sponsor” a collection of information if the agency collects the information, causes another agency to collect the information, contracts or enters into a cooperative agreement with a person to collect the information, or requires a person to provide information to another person, or in similar ways causes another agency, contractor, partner in a cooperative agreement, or person to obtain, solicit, or require the disclosure to third parties or the public of information by or for an agency. A collection of information undertaken by a recipient of a Federal grant is considered to be “conducted or sponsored” by an agency only if:  (1) The recipient of a grant is conducting the collection of information at the specific request of the agency; or (2) The terms and conditions of the grant require specific approval by the agency of the collection of information or collection procedures.

If the Paperwork Reduction Act is applicable after reviewing the applicant’s proposal, then approximately 12-18 months is needed for approval.

Additional information on Office of Budget and Management approval for information collection can be found  on: https://www.cdc.gov/od/science/integrity/reducepublicburden/index.htm

Can questions related to the NOFO be submitted, in writing, before; during; and after the informational call?

Questions can be emailed to Phaeydra Brown at: PBrown1@cdc.gov

Will the questions posed and answers provided during the informational call be compiled and made available on grants.gov or other website or through another mechanism? (The same is true if questions can be submitted after the informational call.)

Frequently asked questions will be posted on: https://www.cdc.gov/chronicdisease/about/foa/cancer-control/index.htm.

Questions can still be sent to Phaeydra Brown at: PBrown1@cdc.gov

A few additional questions from GW: 1. Are references included in 20-page limit? 2. PPT said max 12 pt-- FOA says 12 pt-- is smaller font allowed? 3. Is there a specific formatting for CVs/Resumes- such as NIH bio sketch? 4. Is the budget narrative for all 5 years or just one?

  1. References are not included in the 20-page limit and should be included as other/miscellaneous documents with the Grant application package.
  2.  OGS (Office of Grants Services) requires that the maximum font for Grant applications be 12-point font.
  3. There are no specific formatting for either curricula vitae or resumes.
  4. Budget narrative will represent the applicant’s year one funding. Five year funding will be outlined on the SF- 424a grant application form.

Are recipients of the National Comprehensive Cancer Control Program eligible to apply for support through DP18-1805? Related Question: I came across a call for “Provision of Technical Assistance and Training Activities to Assure Comprehensive Cancer Control Outcomes” Do you think foreign institutions are eligible to apply ?

This Notice of Funding Opportunity (NOFO) is unrestricted and open to any type of entity. Applicants must fully demonstrate capacity to carry out the strategies as outlined in Section C. Organizational Capacity of Recipients to Implement the Approach page 16 – 17. In addition, the applicant must respond to the evaluation criteria listed on page 35.

Please clarify applicant requirements for performance measurement and project period objectives that should be part of the applicant’s workplan.

Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. As a part of the evaluation and performance measurement plan, the applicant must describe collection of performance measures specified in pages 14 – 15 of the NOFO.

In addition, the applicants must also provide a workplan that aligns with the strategies outlined in this NOFO. The workplan must include project period objectives as outlined on page 17. Each project period objective should be linked to a related program strategy and one or more annual objectives that support how the project period objective will be achieved after completion of the five-year funding period. Key activities to support each annual objectives must also be included. In summary, major components of the applicant’s workplan include: project period objectives, annual objectives, activities, lead personnel, key partners/contractors, and start/finish dates.

How should applicants select performance measures to be included in their Applicant Evaluation and Performance Measurement Plan as specified on pages 14 – 15?

Applicants are required to respond to all Tier 1 measures that are aligned with intermediate outcomes:

  • Number of state, tribal, and/or territorial cancer control programs with demonstrable increased capacity to implement evidence based policy, system and environmental change interventions to address healthy lifestyles (e.g., tobacco use prevention; obesity; alcohol consumption) as a result of technical assistance from the awardees as demonstrated by the increase in the number of programs demonstrating that evidence.
  • Number of state, tribal, and/or territorial cancer programs with increased capacity to implement health systems change interventions to increase breast, cervical, colorectal, and lung cancer screening rates, as demonstrated by the increased number of health systems change interventions initiated in programs.
  • Number of state, tribal, and/or territorial cancer programs with increased capacity to implement community clinical linkage interventions to improve the quality of life and healthy lifestyle behaviors of cancer survivors.

In addition, applicants must select three of the following six Tier 2 measures that are aligned with long term outcomes:

  • Percent decrease in the prevalence of adults aged 18 years and older who are current smokers in identified priority populations (to be determined by the recipient based on cancer burden data). Consideration should be given to underserved or underrepresented populations, or cancer survivors.
  • Percent increase in the prevalence of adults meeting 150 minutes of physical activity/week in identified priority populations (to be determined by the recipient based on cancer burden data). Consideration should be given to underserved or underrepresented populations, or cancer survivors.
  • Breast cancer screening: % increase of women aged 50-74 years in priority population who have had a mammogram in the past 2 years.
  • Cervical cancer screening: % increase of women aged 21-65 years in the priority population who have been screened for cervical cancer within the past 3 years;
  • Colorectal cancer screening: % increase of adults aged 50-75 years in the priority population who have been screened for colorectal cancer.
  • Percent increase in cancer survivors indicating that their overall health was excellent, very good, or good after receiving a survivorship care plan or participating in a lifestyle program.

Tier 2 measures used gendered language; however, disproportionately burdened populations are defined on page 13 by sex, race, ethnicity, disability, sexual orientation, gender identity, geographic location (particularly rural and frontier areas), low health literacy, uninsured, or socioeconomic status. Can Tier 2 measures be modified to specify target population listed in the Health Disparities section?

Tier 2 measures are based on United States Preventive Services Task Force recommendations and can be tracked through available CDC surveillance systems (US Cancer Statistics and Behavioral Risk Factor Surveillance System); therefore, these measures cannot be modified. This does not preclude applicants from seeking to achieve health equity by targeting efforts on populations disproportionately affected by cancer. Applicants are expected to monitor and tract these efforts appropriately in addition to reporting Tier 2 measures.

Can applicants use funding to convene, staff, and/or support the Comprehensive Cancer Control National Partnership?

While this NOFO will not fund the CCCNP or other partner networks directly, program funds may be used to support the facilitation of partner network efforts to achieve activities related to the core strategies of this NOFO.

P14 of the NOFO describes the National Colorectal Cancer Roundtable as an organization not funded by CDC. Please clarify if award dollars can be used to convene, staff, and help support the work of the NCCRT.

Yes, the NOFO can support collaborations of the NCRCRT. Review page 9 of the NOFO, under Core Strategy 3: Coordinate and collaborate with existing partnership networks: award recipients need to develop a process to 1) identify and sustain appropriate engagement strategies (i.e., progression from networking, to coordination, collaboration, and cooperation); 2) communicate and update partners on technical assistance and training strategies; 3) secure commitment to provide technical assistance and training; and 4) share resources and information.

Program funds may be used to support the facilitation of partner network efforts to achieve activities related to the core strategies of this NOFO.

 Top of Page
TOP